Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
China
· Delayed Price · Currency is CNY 7.08
+0.16 (2.31%)
Apr 30, 2026, 3:00 PM CST
SHA:600351 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 4,789 | 4,491 | 4,385 | 5,215 | 4,528 | 6,992 | Upgrade
|
| Market Cap Growth | 8.59% | 2.42% | -15.93% | 15.19% | -35.24% | 82.33% | Upgrade
|
| Enterprise Value | 3,900 | 3,899 | 3,952 | 4,911 | 4,520 | 7,195 | Upgrade
|
| Last Close Price | 6.92 | 6.30 | 5.63 | 6.23 | 5.27 | 8.04 | Upgrade
|
| PE Ratio | 15.08 | 14.03 | 18.07 | 26.13 | 43.26 | 37.37 | Upgrade
|
| Forward PE | - | 15.89 | 15.89 | 15.89 | 15.89 | 15.89 | Upgrade
|
| PS Ratio | 2.18 | 2.01 | 1.63 | 1.79 | 1.67 | 2.53 | Upgrade
|
| PB Ratio | 1.71 | 1.59 | 1.52 | 1.74 | 1.51 | 2.36 | Upgrade
|
| P/TBV Ratio | 1.78 | 1.65 | 1.61 | 1.87 | 1.62 | 2.59 | Upgrade
|
| P/FCF Ratio | 8.36 | 8.56 | 10.03 | 13.11 | 11.37 | 20.42 | Upgrade
|
| P/OCF Ratio | 7.78 | 7.83 | 9.30 | 10.48 | 9.83 | 15.98 | Upgrade
|
| PEG Ratio | - | 2.55 | 2.55 | 2.55 | 2.55 | 2.55 | Upgrade
|
| EV/Sales Ratio | 1.77 | 1.74 | 1.47 | 1.69 | 1.66 | 2.60 | Upgrade
|
| EV/EBITDA Ratio | 7.97 | 8.06 | 9.57 | 10.98 | 13.37 | 19.77 | Upgrade
|
| EV/EBIT Ratio | 11.07 | 11.15 | 14.28 | 16.85 | 25.38 | 36.59 | Upgrade
|
| EV/FCF Ratio | 6.81 | 7.43 | 9.04 | 12.35 | 11.35 | 21.01 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.03 | 0.07 | 0.15 | 0.18 | Upgrade
|
| Debt / EBITDA Ratio | 0.08 | 0.07 | 0.23 | 0.46 | 1.29 | 1.47 | Upgrade
|
| Debt / FCF Ratio | 0.06 | 0.07 | 0.22 | 0.53 | 1.11 | 1.57 | Upgrade
|
| Net Debt / Equity Ratio | -0.30 | -0.28 | -0.17 | -0.14 | -0.07 | 0.02 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.71 | -1.62 | -1.17 | -0.91 | -0.67 | 0.17 | Upgrade
|
| Net Debt / FCF Ratio | -1.45 | -1.49 | -1.10 | -1.03 | -0.57 | 0.18 | Upgrade
|
| Asset Turnover | 0.64 | 0.66 | 0.73 | 0.73 | 0.66 | 0.68 | Upgrade
|
| Inventory Turnover | 3.15 | 2.92 | 3.10 | 2.80 | 2.51 | 2.15 | Upgrade
|
| Quick Ratio | 3.05 | 3.12 | 1.83 | 1.60 | 1.40 | 1.23 | Upgrade
|
| Current Ratio | 3.92 | 4.10 | 2.68 | 2.23 | 1.88 | 1.79 | Upgrade
|
| Return on Equity (ROE) | 10.49% | 10.49% | 7.61% | 6.00% | 3.50% | 6.36% | Upgrade
|
| Return on Assets (ROA) | 6.43% | 6.40% | 4.68% | 4.56% | 2.71% | 3.04% | Upgrade
|
| Return on Invested Capital (ROIC) | 14.27% | 12.58% | 8.49% | 8.93% | 5.11% | 5.84% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.30% | 12.10% | 9.30% | 9.50% | 5.80% | 6.40% | Upgrade
|
| Earnings Yield | 6.67% | 7.13% | 5.54% | 3.83% | 2.31% | 2.68% | Upgrade
|
| FCF Yield | 11.97% | 11.69% | 9.97% | 7.63% | 8.80% | 4.90% | Upgrade
|
| Dividend Yield | 5.79% | - | 5.33% | 2.41% | 0.95% | 1.00% | Upgrade
|
| Payout Ratio | 109.47% | 66.21% | 46.79% | 25.69% | 77.98% | 32.29% | Upgrade
|
| Buyback Yield / Dilution | 2.72% | 3.29% | 5.25% | 0.89% | -0.02% | 0.04% | Upgrade
|
| Total Shareholder Return | 8.62% | 3.29% | 10.58% | 3.30% | 0.93% | 1.03% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.